CRM YTD mountain Salesforce stock in 2025. Roughly 81% of analysts surveyed by FactSet have a buy rating on Salesforce, but their consensus 12-month price target would amount to even more upside — 35% over the next year. Other companies that Wall Street likes in the second half are BioMarin Pharmaceutical, Light & Wonder, Fiserv and Burlington Stores.